Dr. Eli Hatchwell is the Chief Scientific Officer and co-founder of Population Diagnostics and has engaged in genetic research for 20 years including as an Investigator at Cold Spring Harbor Laboratory and, most recently, an Associate Professor and Director of the Genomics Core Facility at SUNY at Stony Brook.
Dr. Eli Hatchwell is a member of ICare4Autism’s Advisory Council which performs autism research in Israel and will be speaking at ICare4Autism’s International Autism Conference in Jerusalem this August. He will be speaking about the heritability of autism and will discuss the recently completed project he was involved with which discovered many novel genes in connection with autism.
Dr. Hatchwell’s clinical and technical expertise in investigating human genetic disorders led him to recognize early on that human genetic diversity was grossly underestimated, there was a critical need to comprehensively understand the vast spectrum of normal genetic variation in the population and that rare variants are largely responsible for causing common disease – the underlying principles of the genetic biomarker discovery technology of Population Diagnostics.
He is recognized as a key collaborator in the development of one of the first genome-wide BAC-based comparative genomic hybridization (CGH) microarray platforms and remains at the forefront of cytogenetic and genome analysis through early adoption of leading edge technologies. Dr. Hatchwell collaborates with human genetics researchers worldwide, is a coauthor on numerous peer-reviewed articles, encompassing both clinical genetics and genome technologies, and is senior editor of a book series aimed at educating medical specialists on genetic principles and practices.
Dr. Hatchwell is also a certified Medical Geneticist (UK) with many years of experience in clinical practice. He received his medical degree from the University of Cambridge, his DPhil in Molecular Genetics from the University of Oxford, and was a Wellcome Advanced Clinical Training Fellow. He also holds a degree in Mathematics from the Open University (UK).
His goal is to get together as many genes to formulate tests that are as comprehensive as possible so that autism could be diagnosed medically before clinically. He is also interested in matching genetic causes of autism to potential therapeutic interventions. He believes these complex genetic disorders, will eventually be found to be amalgams of very a variety of very rare disorders.